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                               INTRODUCTION 
 
 
The  prevalence  of  HIV infection  is  on  increase  particularly  in  the  developing  countries . 
 
Accordingto  a  paper   from  UNAIDS/WHO  in   2015 , there  are  about  36.7  million  HIV 
 
infected patients currently  in  the   entire world. There are about 2.1million  whowere  newly 
 
diagnosed worldwide. 1.1  million  patients  expired  due  to  AIDS  in  2015. 
 
 
Therefore  the  incidence  of  HIV  is  on the increase and  hence  the  incidence  of 
 
surgical  conditions  among  the  HIV  patients  are  also  in  increase  as survival  rate  is 
 
increasing  due  to  the  advent  of  effective  anti-retroviral  therapy  with multiple drugs. 
 
 
 
The  reason  for  increase  in  the  HIV  infection  rate  in  developing  countries  like  India, 
 
Africa  is  due  to  the   lack  of  awareness ,  multiple sexual partners ,  intravenous  drug 
 
abuse , and  unscreened  blood  transfusions. 
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Though  unscreened  blood  transfusions  have  decreased  due  to  awareness ,  there  is  steady   
 
increase  in  the  rate  of  unsafe unprotected  sex  with  multiple  partners ,  premarital  sex  and   
 
extramarital sex. Since  the  number  of  HIV  patients  are  raising  day  to  day  and  the   
 
diagnosis  is  becoming very  easy,  early  detection,  careful  follow  up,  counseling  and   
 
proper  institution  of antiretroviral  therapy  has  led  to  the  increase  in  the  life  expectancy   
 
of  the  HIV/ AIDS patients.  Hence  the  opportunistic  infections  are  increasing  which  is   
 
dependent  on  the  CD4  counts  of  the  Patient  though  the  opportunistic  infections  are   
 
mainly  medical diseases,  there  are  few  surgical  conditions   which   occur  in  HIV  patients    
 
which lackproperdata.  This initiated a drive to learn about the prevalence of surgical disease  
 
in HIV / AIDS . 
. 
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AIM OF STUDY 
 
o To definethe prevalenceof  all surgical conditions  among HIV infected  
 
patients attending the surgical/surgical superspecialityOPDs/ In patients/ Surgical  
 
casualty  of TMCH , THANJAVUR 
 
o To study the prevalence of all surgical conditions among AIDS patients  
 
attending the ART OPDof TMCH , THANJAVUR 
 
o To study about various Acute surgicalemergencies in HIV/AIDS patients  
 
 
o To study age and sex incidence in these patients. 
 
 
o To know the outcome and management 
 
 
o To study the clinical presentationof  these HIV patients with surgical disease. 
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HISTORICAL ASPECTS 
 
The firstincidence of this new syndrome came in 1981 withtwo reports from  New york 
 
 and  Los Angeles of the outbreak of two rare diseases namely Kaposi sarcoma  
 
and pneumocystiscarinii pneumonia .In 1983lucmontagnier from Pasteur institute 
 
isolated a retrovirus from west African patient with persistent generalized 
 
lymphadenopathy and called Lymphadenopathy associated virus . In 1984Robert Gallo  
 
fromNationalInstitute of Health, USAcalled itHumanT-cellLymphotropicVirus 
 
type3. In 1985   ELISA came available for the detection of HIV.In  1986  the  term  HIV   
 
was  coined. 
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REVIEW OF LITERATURE 
 
ETIOLOGY: 
 
AIDS,  AcquiredImmuno   Deficiency   Syndrome   is   a   clinical   syndrome   caused   by    
 
Human  Immunodeficiency   Virus  [HIV].   HIV   viruses   are   RNA   viruses   that   belong     
 
to   the  family   Retroviridae.   RETRO   means   backward    in   Latin. 
 
 
The   viruses   of   this   family   possessan   enzyme   called   as   Reverse   transcriptase. 
 
The   function   of   reverse   transcriptase   is   that   they   produce   DNA   copy    of   RNA    
 
genome   in   the   cells   of   their   host.  Hence  reverse  transcriptase  enzyme  is  the   
 
characteristic  of  these  viruses .  
 
CLASSIFICATION  
 
TheRetroviridae family is divided into 2 sub families : Orthoretrovirinae and  
 
Spumaretrovirinae. There are seven genera in this particular family, out of these 7, only  
 
2 family has retroviruses that infect human. They are the Lentivirus and Retrovirus. 
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Orthoretrovirinae 
 
Genus Retro Virus Genus Lenti Virus 
Human T-cell 
Lymphotropic virus 
Type 1 (HTLV-1)-
oncogenic virus 
HTLV-2 
Human Immuno 
Deficiency Virus  
Type-1 Type-2 
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HTLV-1 causes Adult T- cell Leukemia / Lymphoma. 
 
HTLV-2 is not associated with any disease but it has been noted in intravenous drug  
 
abusers. HIV -1 and 2 are responsible for clinical syndrome of AIDS . 
 
MORPHOLOGY: 
 
HIV is a spherical enveloped virus , about 90-120 nm in diameter . 
 
It has two similar copies of single stranded positive sense   RNAgenome . In association 
 
with this RNA is the enzyme reverse transcriptase . The virus core is surrounded by a 
 
nucleocapsid  which has protein . It also contains an envelope which is lipoprotein in 
 
nature which contains lipid derived from the host cell membrane and glycoproteins  
 
which are virus coded. The major virus coded envelope glycoproteins are the spikes  
 
projecting on the surface and the anchoring trans membrane pedicles . These spikes  
 
bind to the receptors- CD4 on the host cells which are susceptible .  Transmembrane 
 
pedicles cause cell fusion .  
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The HIV genome consist of 3 structural genes namely gag ,pol and env which are  
 
characteristic of all retro viruses . There are five non – structural genes namely the  
 
vpr ,vif , nef, rev and tat which are present in both HIV -1 and HIV – 2 . HIV-1 
 
specific gene is vpu and HIV-2 specific gene is vpx .  
 
Hence infected patients serum will have antibodies to these antigens . The detection of  
 
these antigens and antibodies is of great importance in the diagnosis and prognosis of  
 
HIV/ AIDS  
 
Table:1 –The genetic products of HIV ( HIV antigens )
 
Gene 
gag 
pol 
env 
Coding of HIV antigens 
(a) Shell Antigen 
(b)Core Antigen 
Envelope 
antigen  
Reverse 
transcriptase 
antigen 
Antigens 
p18 (nucleocapsid 
protein ) 
p24 ( principal core 
antigen ), p 15 , p 55 
gp120 (principal 
envelope spike antigen) 
gp41 (transmembrane 
antigen) 
p31 , p51 , p64 
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ANTIGENIC VARIATION : 
 
 
HIV often undergoes antigenic variation of core and envelope antigens.Two different  
 
antigenic types of HIV have been identified – HIV-1 and HIV-2. Antigenic variation 
 
occurs within both the species HIV-1 and HIV-2. HIV-1 represents the original isolate  
 
from America , Europe and the other Western countries , whereas HIV-2 represents  
 
isolates predominantly from West Africa which weakly reacts with HIV-1 antisera .  
 
The envelope antigens of the two types are not the same. Their core polypeptides show  
 
some cross reactivity. HIV-2 is more closelyrelated  to simian immunodeficiency virus rather  
 
than HIV-1.  
 
HIV-1 strains have been classified into ten subtypes A to J , based on sequence analysis of their  
 
gag and env genes . 
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Antigenic differences between various HIV strain may be essential in lab diagnosis.  
 
 Infections by HIV-1 or HIV – 2 may not be identified unless the corresponding type is  
 
utilized in the test antigen. It is also important to use antigens containing the prevalent  
 
subtypes in different countries .  
 
The subtypes seem to vary in frequency by various routes . 
 
Subtype C and E --- Common in Asia and Africa – heterosexual contact  
 
Subtype B --- Americans strains – blood borne – by injection and homosexual contact. 
 
 
Subtypes 
A 
B  
A,C,D 
E,C,B 
E 
C 
Found in 
worldwide 
Common in America and Europe 
Africa 
Asia 
Thailand 
India and China 
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CELL TROPISM: 
 
 
HIV infects all cells expressing at their surface the CD4 
antigen, which is  the receptor for the virus. 
The spikes (gp120) of the viral envelope specifically 
attaches to the CD4 antigen and antibodies to CD4 protein 
block the virus binding site. 
T4 Lymphocytes are mainly involved in HIV infectkion but 
other human cells which expresses   CD4 are also 
susceptible. These cells are 5-10% of B lymphocytes , 10-
20% of monocytes and macrophages . CNS containing 
Glial cells and microglia  are  also infected. 
After binding to CD4 of host cell , the gp 41 terminus is 
exposed and host cell membrane compiles with the viral 
membrane. Thus the viral core enters the cytoplasm of 
the host cell. Cell fusion and virus entry also requires a 
corereceptor molecule , which is identified as CXCR4 for T 
cell -tropic HIV strains and CCR5 macrophage-tropic 
strains. 
Infected CD4 cells  express  a huge level of gp 120 on their 
surface . The gp 120 on the surface of infected cells will 
lead to fusion of cells with C protein of non-infected near 
by cells , with formation of multinucleated syncytial cells. 
Lysis of fused cells  atlast occur resulting in depletion of 
many number of non-infected cells from the circulation. 
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FIGURE:1:(a) HIV structure (b) HIV infecting a T cell with CD4 receptors and CXCR4  
Coreceptor: 
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RESISTANCE: 
 
 
Detergents: Due to the presence of lipid membrane in its envelope, it is highly susceptible  
 
to detergents , hence, washing with detergents is adequate for decontaminating clothes and  
 
household utensils.  
 
 
Temperature: HIV is sensitive to heat , being inactivated at 56*c in 30 minutes and in  
 
seconds at 100*c. At roomtemperature , it may survive up to a week 
 
 
Disinfectants: It is inactivated in 10 minutes by treatment with 2% freshly prepared  
 
glutaraldehyde , 70% ethanol , 0.5 % Lysol , 35% isopropyl alcohol and 3 % hydrogen  
 
peroxide . For treatment of contaminated medical instruments , a 2% glutaraldehyde  
 
solution is useful. 
 
 
Lyophilisation: The virus withstands Lyophilisation. 
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MODES OF TRANSMISSION: 
 
There are 3 main modes of transmission  
 
Sexual contact, parenteral and perinatal . 
 
 
1.Sexual contact (0.1-1.0%): It is the most important mode of transmission. Sexual  
 
transmission takes place between homosexual as well as heterosexual individuals. HIV has  
 
been separated from semen , which are the important modes of transmission. The risk of  
 
acquiring HIV infection develops if genital ulcers are present , as in syphilis or chancroid .  
 
Risk is also is hugely prevalent if more than one sexual partners are there. 
 
 
2.Parenteral Transmission (>90%): This occurs after receiving infected  
 
blood transfusions, products of blood , sharing contaminated syringes and needles. It happens    
 
inintravenous drug abusers or accidental inoculation as well. 
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3.Perinatal transmission (30%): Infection can be transmitted from a mother who is  
 
Infected, to her new born either transplacentally or perinatally . At the time of birth , 
 
infection can also develop from the genital secretions and mothers milk after birth. 
 
 
PATHOGENESIS: 
 
 
After its entry into the blood stream , HIV comes in contact with the suitable host cells  
 
mainly the CD4  lymphocytes . Once it enters the cell , RNA is transcribed by reverse  
 
transcriptase into DNA (provirus). The provirus is integrated in the genome of infected  
 
cell causing latent infection . Long and variable incubation time of HIV infection is because  
 
of initiated and release of progeny virions to infect other cells . In infected , HIV can  
 
be isolated from blood, cell free plasma , semen , breast milk, urine, tears , cervical  
 
secretions and saliva. 
 
Infection  causes damage to T4 lymphocytes . T4 cells are decreased in numbers and T4:T8  
 
(helper :suppressor) ratio is reversed. Viral infection can depress the function of infected  
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cell without damaging. This leads to the recognized damping effects on Cell Mediated Immunity.  
 
Functions of other cells (macrophage and monocytes ) areaffected apparently due to the absence  
 
of secretion of activating factors by T4 lymphocytes. 
 
Clinical manifestations of HIV infections are due to failure of immune responses. This  
 
renders the patient susceptible to life threatening opportunistic infections and malignancies .  
 
Degenerative neurological lesions and Dementia can also be seen in AIDS. This may be  
 
because of the direct effect of HIV on Central Nervous System.  
 
 
CLINICAL FEATURES : 
 
 
The clinical course of the infection with HIV can present as follows : 
 
1.Acute HIV infection : The illness is mainly characterized by acute onset of fever , malaise ,  
 
myalgia , skin rash , arthralgia  , sore throat, and lymphadenopathy. Peripheral blood shows  
 
lymphocytosis . Viral nucleic acid or viral p24 antigen can be detected during acute infection.  HIV  
 
antibodies are negative at the onset of illness but become positive during the course. 
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2.Asymptomatic infection: It includes all infected persons who are clinically normal. They show  
 
positive HIV antibody tests , and are infectious. 
 
3.Persistent generalized lymphadenopathy(PGL) : This group is mainly characterized by  
 
enlarged nodes at 2 or more extragenital sites for atleast 3 months. PGL must be differentiated  
 
from other causes of lymphadenopathy. 
 
4.Symptomatic HIV infection : When CD4+ T lymphocyte count decreases below 400 per mm
3 
 
the patient can develop symptoms like diarrhoea , night sweats , opportunistic infections, weight  
 
loss and fever . During this condition some patients may develop an illness known as AIDS related  
 
complex or condition(ARC). 
 
 
When CD4 + cells fall below 200per mm
3
 , the titre of virus will increase markedly and there will  
 
be irreversible breakdown of immune defence mechanisms, it is what  is called as AIDS . Most of  
 
the patients with HIV disease die of infections other than HIV e.g. opportunistic infections and  
 
malignancies . AIDS is terminal stage of HIV infection. 
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In addition to  opportunistic infections , patients can develop primary CNS lymphoma and  
 
progressive multifocal leukoencephalopathy myelopathy, Dementia , peripheral neuropathy, severe  
 
encephalopathy, motor disturbances and diminished concentration may develop inpatients with  
 
HIV infections. 
 
 
Opportunistic infections and malignancies commonly assosciated with HIV infection 
 
i. Bacterial 
1.Salmonellosis 
2.M.avium complex 
3.Mycobacterial infections – Tuberculosis and non tuberculous infections . 
 
 
ii. Mycotic 
1.Histoplasmosis 
2.Coccidiodomycosis 
3.Candidiasis 
4.Aspergillosis 
5.Pneumocystisjiroveci pneumonia 
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iii. Viral 
 
1.CMV 
2.Varicella –Zoster 
3.Herpes simplex 
4.Epstein –Barr (EB ) virus/ 
5.Human herpes virs 6(HHV6) 
6.Human herpes virus (HHV8) 
 
iv. Malignancies 
 
1.Kaposis sarcoma 
2.B-cell lymphoma or non –Hodgkins Lymphoma 
 
v. Parasitic 
 
1.Isosporiasis 
2.Generalizedstrongyloidiasis 
3.Toxoplamosis 
4.Cryptosporidiosis 
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CLINICAL TYPES 
 
Incubation period of AIDS varies from 1-14 years , with an average of 6 years . 
 
1.AIDS in Adults 
 
Risk factors for AIDS include: 
i. Blood transfusion 
ii. Intravenous drug abusers 
iii. Anal and genital sex 
iv. Haemophiliacs treated with blood or blood products 
 
2.Paediatric AIDS 
 
  Infection is transmitted from 
i. Transfused blood or blood products  
 
ii. Infected mothers 
 
Kaposissarcoma , toxoplasmosis and cryptococcosis are commonly seen in adults but less  
 
commoninchildren. 
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CLINICAL RESPONSE TO HIV IN ADULTS 
 
 
 
Exposure to HIV 
Infection 
Persistant generalized 
Lymphadenopathy (PGL) 
 
Asymptomatic 
ARC           AIDS 
Acute Infection 
No Infection 
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Four clinical stages of AIDS for adults and adolescents with confirmed infection has been defined  
 
by World Health Organization. Initiation of anti retroviral therapy is based on these clinical  
 
stages. 
 
WHO Clinical staging of HIV in adults and adolescents with HIV infection confirmed 
 
Clinical stage 1 
 
 Persistent generalized lymphadenopathy 
 
 Asymptomatic 
 
Clinical Stage 2 
 
 Herpes Zoster 
 
 Seborrheic dermatitis 
 
 Fungal nail infections  
 
 Angular cheilitis 
 
 Recurrent oral ulceration  
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 Recurrent respiratory tract infections (e.g. tonsillitis , otitis media , pharyngitis, sinusitis ) 
 
 Moderate unexplained weight loss (<10% of presumed or measured body weight ) 
 
 Popular pruritic eruptions 
 
 
 
Clinical stage 3 
 
 Pulmonary tuberculosis (current) 
 
 Unexplained anemia (<8g/dl) , neutropenia ( <0.5 x109/L) 
 
 Chronic thrombocytopenia (<50x109/L) 
 
 Persistent oral candidiasis  
 
 Oral hairy leukoplakia  
 
 Unexplained severe weight loss (>10% of presumed or measured body weight ) 
 
 Severe bacterial infections (e.g., pneumonia, pyomyositis, empyema,bacterial  bone or joint  
 
infection , meningitis ) 
 
 Acute necrotizing ulcerative stomatitis , periodontitis or gingivitis 
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 Unexplained chronic diarrhoea for longer than 1 month  
 
 Unexplained persistent fever ( above 37.6*c , intermittent , constant , for longer than 1  
 
month ) 
 
Clinical Stage 4 
 
 Pneumocystis jirovecii 
 
 HIV encephalopathy 
 
 Extra pulmonary tuberculosis  
 
 Chronic isosporiasis 
 
 Central nervous system toxoplasmosis 
 
 Progressive multifocal leukoencephalopathy 
 
 HIV wasting syndrome 
 
 Recurrent severe bacterial pneumonia 
 
 Lymphoma ( cerebral or B-cell non –Hodgkin’s ) or other solid HIV – associated tumors 
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 Kaposi’s Sarcoma 
 
 Disseminated nontuberculous mycobacterial infection 
 
 Disseminated mycosis 
 
 Invasive cervical carcinoma 
 
 Recurrent nontyphoidal Salmonella bacteraemia 
 
 Symptomatic HIV – associated nephropathy or symptomatic HIV- associated  
 
cardiomyopathy 
 
 Atypical disseminated leishmaniasis 
 
 Extra pulmonarycrytococcosis , including meningitis 
 
 Chronic herpes simplex infection ( genital, orolabial, or anorectal , longer than 1 months  
 
duration , or visceral) 
  
 Oesophagal Candidiasis ( Candidiasis of lungs, bronchi, trachea ) 
 
 
Unexplained means the condition which is not explained by other causes. 
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LABORATORY DIAGNOSIS 
 
Laboratory diagnosis of HIV infection includes specific tests for the virus and tests for 
immunodeficiency. 
 
1.Non specific tests 
 
i. Platelet count 
 
ii. T-lymphocyte subset assays  
 
iii. Total and differential leucocyte count 
 
iv. IgG and IgA levels 
 
v. Skin tests for CMI 
 
2.Specific tests for HIV infections 
 
i. Antibody detection 
 
ii. Detection of viral nucleic acid 
 
iii. Antigen detection : p24 antigen  
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iv. Virus isolation 
 
NON-SPECIFIC TESTS 
 
Total and differential leucocyte count 
In AIDS , there is leucopenia with a lymphocyte count less than 400 per mm
3
 
 
Platelet count  
There is thrombocytopenia in patients of AIDS 
 
T-lymphocytes subset assays 
The normal CD4:CD8 T-cell ratio of 2:1,is reversed to 0.5:1 incases of AIDS. The count of CD4  
 
lymphocytes falls below 200mm
3 
 
Platelet count 
There is a thrombocytopenia in patients of AIDS 
  
IgG and IgA levels 
Both IgG and IgA levels are raised 
 
Skin tests for CMI 
Cell mediated immunity is decreased as seen from tuberculin test or other skin tests for CMI 
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SPECIFIC TEST  FOR HIV INFECTION 
 
Antibody detection 
 
Demonstration of antibodies is the simplest and most commonly used technique for diagonosis.It 
 
requires several weeks to months for antibodies to appear after infection.IgM antibodies appear 
 
first usually in about 3-4 weeks after infection,to be succeeded by IgG antibodies.IgM antibodies 
 
disappear in 8-10 weeks while IgG antibodies remain throughout life.Due to severe AIDS,some 
 
components of anti-HIV antibody  may diappear.eg.anti-p24. 
 
  HIV affected  patients  remain negative for antibodies during window period,when initial  
 
viral replication occurs for about 2-3 weeks . 
 
The diagnosis of HIV infection is done by detecting serum antibodies to viral  
 
proteins,both core (p24) or envelope (gp120,gp41).The serological tests are 
 
 Screening  
 
 Supplemental 
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Detection of viral nucleic acid 
 
Viral nucleic acid can be identified by polymerase chain reaction(PCR) .Two types of  
 
PCR have been used ,DNA PCR and RNA PCR..In  the DNA PCR ,peripheral lymphocytes are  
 
lysed and the proviral DNA is amplified. The test is highly specific and sensitive. The related  
 
test like RNA PCR can be used for diagnosis and also for monitoring the level of viraemia.The  
 
PCR tests are costly which are indicated only when some other methods give inconclusive  
 
result. 
 
Antigen Detection 
 
           The virus antigen (p24)and reverse transcriptase (RT) may be detected in blood after 
 
about a period of two weeks following a single massive infection.The p24 antigen is the 
 
earliest virus marker to appear in the blood .Antibody becomes detectable with seroconversion 
 
and antigen p24 disappears from circulation and remains absent during the long asymptomatic  
 
phase.The p24 antigenemia reappears with the onset of clinical disease which corresponds to 
 
loss of anti p24 antibody.The p24 capture assay (ELISA) by using the anti p24 antibody as  
  
43 
 
 
thesolid phase  can be used for the detection of this antigen. 
 
 
Viral isolation 
 
Virus is not routinely isolated for diagnosis.Once a personis  infected with HIV,he/she  
 
remains infected for life.The virus which is present in blood and body fluids are mostly within  
 
CD4 lymphocytes.so, it can be isolated from CD4 lymphocytes of peripheral blood and bone  
 
marrow. 
 
    In the presence of Interleukin-2, patients blood sample are co-cultivated with uninfected 
 
humanlymphocytes.Viral replication can be detected by demonstration of reverse  
 
transcriptase activity and presence of viral antigen p24 in the culture fluid. 
 
 Viral titres are more early in infection before antibodies appear.The antibodies do not  
 
detoxify the virus and the two may coexist together in the body duringasymptomatcic infection  
 
viraltitres are less and may not be detected but when clinical disease sets in, titres raise again. 
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Specific tests for laboratory diagnosis of HIV infection 
Test Window period Acute infection Asymptomatic 
infection 
ARC and AIDS 
Antibody 
 
 ELISA test 
 WESTERN  
  BLOT test            
 
_ 
      _ 
 
 
 + 
       + 
 
 
 + 
         + 
 
 
+ 
     + 
 
Virus isolation ++ + 
 
_ + 
Antigen;p24 + + _ + 
 
 
Screening tests 
 
 
ELISA test:    
 
Direct solid phase ELISA is most commonly used.The antigen which is  
 
prepared from HIV is  grown in continuous Lymphocyte cell line by recombinant  
 
technique.The viral antigen is covered along the surface of microtitre , test serum is added and  
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if antibodies are present, it binds to the viral antigen unbound serum is washed away,anti 
 
humangoat immunoglobulin attached to suitable enzyme is added followed by a colour 
 
formingsubstance.If the test is positive,photometrically detectable colour is formed which can  
 
be read by ELISA reader. This is highly sensitive and specific test. 
 
 
              The early diagnostic tests (first generation)used purify lysate as antigens.The second   
 
generations test  used  recombinant viral proteins.The third generations tests  are double antigen 
 
sandwichassay.In this  viral antigens is attached to a solid phase to  which binds antibody  to  
 
HIV from patients serum. Then labelled HIV antigen is added which attaches to the patient’s  
 
antibody and measured.The Fourth generation  test detects both antibody and antigen. 
 
 
             ELISA Test is good screening test and most laboratories use commercial ELISA Kit  
 
which contains both HIV-1 and HIV-2. 
 
 
              Saliva is alternative to serum for antibody testing by ELISA.This is specially useful for 
 
injectable drug users who might have collapsed blood vessel 
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Rapid Test 
 
            These Tests consume less than thirty minutes  and does not require expensive  
 
equipments.This includes Lateral flow assays,Dot blot assays,HIV spot,Coomb’s test and  
 
particle agglutination. 
 
Simple tests 
 
 They take 1-2 hours and do not require expensive equipment. 
 
Supplemental test 
 
Western blot test 
 
                 HIV proteins are separated by polyacrylamide gel electrophoresis.The separated  
 
proteins are blotted into strips of nitro cellulose paper.The strips are reacted with test  
 
sera.Antibodies to HIV Proteins,if present in test serum,combine with different fragments of  
 
HIV. The strips are washed and reacted with enzymes conjugated anti human globulin. 
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The suitable substrate is added which produces color bands.The position of the color bands  
 
indicate  the fragments of antigen with which the antibodies have reacted .In a positive serum,  
 
bands will be seen with multiple proteins.Antibodies to p24(gag gene,core protein)p31(reverse  
 
transcriptase,pol gene)and GP165,GP120 or GP 141(envelope protein,env gene)are detected. 
 
A positive reaction with proteins representing three genes(env,pol ,gag)is conclusive evidence  
 
of HIV infection.The test is considered as positive if it shows bands against at least two of the  
 
proteins:gp41,p31,p24,gp120/160. 
 
 
  Interpretation of Western blot test is   difficult when 
 
bands appear only at one siteas with gp120,p24.A positive result  in anyone screening test  
 
will not be accepted without confirmation.It is the practice to use the Western blot test for  
 
confirmation.The practice now is to perform   either two different typesof  ELISA or any  
 
rapid test with an ELISA.The serumpositive in both tests considers as positive. In case of  
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doubt the sample is retested after one or two months. 
 
Indirect immunofluorescence test: 
 
HIV infected cells are fixed onto the glass slides and then  reacted with serum 
 
followed by fluorescein conjugated anti-human gamma globulin.In a positive test,  
 
apple green fluorescence appears when examined under fluorescent microscope. 
 
 
SRATEGIES FOR HIV TESTING IN INDIA 
 
Strategy 1: 
 
                When serum is subjected to E/R/S test and if positive,the sample is considered as  
 
HIV infected and if negative,the sample is taken as uninfected from HIV.This method is used  
 
for promoting donation safety(organ, blood tissue,)A highly sensitive and reliable kit should 
 
be used for this purpose. 
 
Strategy11A: 
 
                 If the first test (E/R/S) is found to be negative,there is no need for retesting the  
 
sample butin case its positive, it is retested with a second E/R/S test  based on different test  
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principle and different antigen preparation.It is considered as positive after the second E/R/S  
 
test   if second test is positive otherwise it is considered as negative.This strategy is used for  
 
HIV surveillance. 
 
 
Strategy IIB:  
 
 
Serum sample is processed as in strategy IIA , but a sample positive  
 
with first E/R/S test and negative withsecond test  is subjected for third E/R/S test .  
 
The sample is considered as equivocal only if the third test is positive such persons must be again  
 
retested after a period of  2-4 weeks . The sample is reported as negative , if the third test is  
 
negative. Based on the test principle and different antigen preparation , 2-3 different E/R/S tests are  
 
used. A positive report can be given to the person , if the two tests are positive. This method is  
 
used for diagnosis of an individual who are with symptoms suggestive of AIDS clinically. 
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Strategy III: 
 
This strategy  is similar to strategy IIA with  third E/R/S test as a confirmation. Based on  
 
different antigen preparation or test principle , the third test should be done . A serum  
 
testing is positive only if   all the three E/R/S tests are reported as positive. If the serum specimen  
 
is negative in third E/R/S test then it is considered equivocal. These persons must be tested again  
 
after three weeks. If this specimen also provides an equivocal result , then the patient is  
 
considered  as negative for HIV antibody. This strategy is used for detecting of HIV infection in  
 
asymptomatic individuals .  
 
 
Among these strategies the first test  selected should be of highest sensitivity and second and third  
 
testsshould be of  highest specificity to eliminate the chance of false positiveresults.  
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TESTS FOR OPPORTUNISTIC INFECTIONS AND TUMOUR  
 
Opportunistic infections: 
 
These  infections are mostly detected by direct microscopy. But in some cases culture is essential.  
 
Due to decreased immune response, serological diagnosis cannot be reliable. 
 
Tumor: 
 
The persons with AIDS are oftenhave associated malignant tumors. It  is frequently associated  
 
with homosexuals who are having AIDS.Most important of the malignant tumors are B-cell  
 
lymphoma, Kaposi’s sarcoma, non Hodgkin’s lymphoma . Kaposi’s sarcoma is a  
 
malignant vascular tumor which arises from the endothelial cells of blood vessels.It causes  
 
painless  bluish  purple spots usually on the skin ,mucous membranes but also on the internal  
organs.  
 
APPLICATIONS OF SEROLOGICAL TESTS 
 
Serological test for HIV infection are used in the following situations 
 
a) Diagnosis 
 
b) Screening 
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c) Seroepidemiology 
 
d) Prognosis 
 
1.Diagnosis:  
 
Antibody testing can used to examine whether the infection is the there or   not. Following an  
 
exposure, It may be negative . However in acute illness and sometimes in very late cases the  
 
immune system is non reactive. HIV -2 infections are likely to be missed if antibody testing is  
 
done  with HIV-1 antigen only. The serology if negative after two monthsof  infection, serology 
 
need not be  repeated upto 6 months . If antibody testing is negative , 6 months after  
 
exposure , infection is unlikely to  have occured. 
 
2.Screening: 
 
It is done for all donors of blood products, blood, cells , tissues, semen, organs. As the antibody  
 
tests are negative , when the patient is infectious during the earlier stage of infection, screening  
 
cannot rule out of all harmful donors, but it can eliminate  large ,majority of them. If an individual  
 
is positive for HIV antibody he/she should never be allowed  to donate blood or some other  
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biological materials. HIV infection can be transmitted from mother to babybefore , during ,  
 
or after delivery. Therefore antenatal screening may be recommended  . 
 
3.Seroepidemiology: 
 
Serological tests have been helpful in detecting the geographical extent of HIV infection. 
 
4.Prognosis: 
 
Loss of detectable anti p24 antibody shows clinical deterioration  of HIV infection. This is  
 
related with increased viral titre in blood and HIV antigenemia. 
  
 
LABORATORY MONITORING OF HIV INFECTION 
 
The tests used for monitoring course of HIV infection includes  
 
            1. Measurement of HIV RNA 
 
2. CD4+T cell count 
 
The most important among these  is CD 4+ T cell count that indicates immunological  
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competence of the patients.Counts below 350/mm3  indicates  progression of disease and  
 
the  need for antiretroviral therapy. Antiretroviral therapy is started irrespective of CD4+T cell  
 
count in certain conditions.This  includesHepatitis B and Tuberculosis co infections and also 
 
advanced clinical stages- 3 and 4(WHO).If the count falls less than 200/mm
3
, it denotes the risk of  
 
serious infections.HIV RNA measurement is done by reverse transcriptase PCR (RT-PCR)assay. 
 
In the course of treatment, it is essential to measure HIV RNA. 
 
EPIDEMIOLOGY: 
 
HIV  is transmitted through blood,semen ,vaginal fluid and also from infected mother to fetus.It is  
 
mainly sexually transmitted disease.It  can occur in heterosexuals as well as  homosexuals. 
 
The danger of needle stick injury remains in paramedical and medical personnel,though the risk of  
 
infection has been estimated as 1%.Paramedical and medical staffs have to be educated on carrying  
 
forpatients with HIV infection. 
 
Two sero types of HIV are found,HIV1 and HIV2. HIV 1 is world wide in distribution, HIV-2 is  
 
mainly seen in West Africa.AIDS cases  resulting  from HIV 1 OR HIV 2 infections are clinically  
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indistinguishable.Almost 60% adults with HIV infection develop AIDS within  5-10 years and  
 
majority of individuals who are infected develop AIDS eventually. All patients diagnosedas  
 
having AIDS die due to the associated opportunistic disease virtually . 
 
In India ,the first case of HIV infection was found in female sex workers in Chennaiin 1986 and  
 
the first AIDS patient was from Mumbai in the same year. 
 
The major manifestation of AIDS in Africa was profound wasting since then it has been named  
 
as slim disease. 
 
PREVENTION: 
 
The preventive measures  recommended are the following: 
 
1. Avoidance of sharing needles  
2. Safe protected sex 
3. Screening of Blood and blood products 
4. Isolation of AIDS Patient and initiation of treatment 
5. Control of infection 
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Avoidance of sharing needles: 
 
The contaminated needles and syringes must not be shared. 
 
Safe protected sex: 
 
Use of condoms,avoidance of multiple sex partners 
 
Screening of Blood and blood products : 
 
All blood products and blood are to be screened for HIV. It is also applicable for  organ donation  
 
to screen  involvement of cornea ,marrow , kidney , semen and other organs. 
 
Isolation of AIDS Patient and initiation of treatment 
 
Control of infection: 
 
Individuals within risk groups are screened to identify the HIV  infected person. 
 
I. PROPHYLAXIS 
 
There is no effective vaccine  so far . The difficulty faced in producing an effective vaccine is 
 
high rate of mutation of virus. Several strategies have been explored for vaccine preparation . 
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These include immunization with 
i. modified whole virus 
ii. Sub units , based on envelope glycoproteins 
iii. target cell protection by anti CD4 antibody 
 
These candidate vaccines are on clinical trials in humans. 
 
II. ANTIRETROVIRAL THERAPY 
 
Specific treatment with antiretroviral drugs is the mainstay in the HIV management.  
 
HAART ( Highly Active Antiretroviral Therapy ) are highly effective in the inhibition of the  
 
replication of HIV in HIV infected individuals. Yet the major drawback with this therapy is the  
 
selection of resistant mutants. The Anti Retro viral drugs include both nucleoside inhibitors and  
 
non nucleoside inhibitors of enzyme reverse transcriptase,viral protease inhibitors ,integrase 
 
inhibitors , fusion inhibitors and entry inhibitor.These drugs are used in the form of monotherapy  
 
or in various combinations. Highly active antiretroviral therapy includes combinations like 2  
 
nucleoside reverse transcriptase  inhibitors combined with a protease inhibitor. High cost and their  
 
adverse reactions restrict their wide use in developing countries. 
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Apart from the specific Anti RetroviralTherapy , the other measures include  
 
       A.Prophylaxis and treatment of opportunistic infections and tumors  
       B.General management 
       C.Immuno-restorative measures 
 
POSTEXPOSURE PROPHYLAXIS (PEP) 
 
There is a risk of acquiring HIV infection  with exposure to body fluids, blood,other infected  
 
material and by  contaminated instrument. The risk of infection vary with  the type of exposure and  
 
other factors. Health workers are normally at very low risk of acquiring  
 
infection during management of infected patients.  Following exposure , post exposure prophylaxis  
 
(PEP) may be required depending upon the type of exposure and HIV status of  exposure source.  
 
Basic PEP regimen contains two drug combinations while expanded PEP regimen is of three  
 
drugs. Zidovudine 300mg BD and lamivudine 150mg BD  are the fundamental two drug regimen.  
 
In expanded three drug PEP regimen protease inhibitor is added to this combination of two drugs. 
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 Among the protease inhibitors, Ritonavir 100mg BD or 200 mg OD or Lopinavir 400mg BD or  
 
800mg OD are mostly used as third drug. These drugs are effective if started within  
 
the first 72 hours and ideally within 2 hours.The PEP should be continued for a  
 
period of 4 weeks. Before starting PEP, the risk of infection and possible side effects of antiretro 
 
viral drugs must be carefully considered. In addition to PEP the injured site must be thoroughly  
 
cleaned with soap and water. Antiseptics arealso preferred. 
 
Exposed persons should have post PEP HIV testing, at three months and at six months.  
 
If the test at 6 months after exposure is negative, no further testing is required. 
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ANTIRETROVIRAL DRUGS 
 
Protease inhibitors 
 
 Tipranavir (TPV) 
 Ritonavir (RTV) 
 Amprenavir 
 Darunavir (DRV) 
 Saquinavir (SQV) 
 Indinavir (IDV) 
 Atazanavir (ATV) 
 Fosamprenavir (FPV) 
 Nelfinavir (NFV) 
 Lopinavir (LPV) 
 
Fusion inhibitor 
 Enfuviritide (T20) 
 
Nucleoside reverse transcriptase inhibitors ( NRIs) 
 Abacavir (ABC) 
 Zalcitabine (ddc) 
 Tenofovir 
 Zidovudine (AZT , azidothymidine ) 
 Didanosine (ddI) 
 Stavudine (d4T) 
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 Emitricitabine (FTC) 
 Lamivudine (3TC) 
 
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) 
 Efavirnez (EFV) 
 Etravirine (ETR) 
 Delaviridine (DLV) 
 Nevirapine (NVP) 
 
Integraseinhibitor 
 Raltegravir (RAL) 
 
Entry inhibitor ( CCR5-Co-receptor antagonist ) 
 Maraviroc (MVC) 
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Combination formulas of Antiretroviral drugs 
 
 
 
 
 
 
 
NAME 
Truvada 
Epzicom 
Atripla 
Combivir 
Triomune 
Trizivur 
COMBINATION 
Tenofovir + emtricitabine 
Zidovudine + abacavir 
Tenofovir + emtricitabine + efavirenz 
Zidovudine + lamivudine 
Stavudine + lamivudine + nevirapine 
Zidovudine + lamivudine + abacavir 
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PRINCIPLES OF THERAPY OF HIV INFECTION: 
 
1. Progression of HIV leads to damage of the immune system and progression to AIDS 
 
2. The magnitude of HIV replication and the rate of CD4+ T-cell destruction is 
indicated by the plasma HIV RNA levels 
 
3. CD4 count indicates the level of competence of the immune system. 
 
4. The progression of the disease rate differ among individuals and the decision on 
treatment should be individualized and should be based on the plasma HIV RNA 
and CD4 levels 
 
5. Pregnant females should continue ART treatment. 
 
 
6. Compliance is more important to ensure maximal effect from a given regimen. 
 
7. The simple the regimen, easy for patient compliance. 
 
8. Maximal inhibition of replication of the virus is the aim of therapy. 
 
9. Greater the inhibition of viral replication, lesser the chance of developing drug 
resistant quasispecies. 
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10. The principles are same for children and adults. 
 
11. HIV infected children are to be treated with unique pharmacologic, immunologic 
and virologic aspects. 
 
12. The number of drugs available is limited. Hence decision on anti retroviral treatment 
has a long term impact on further options for the patient. 
 
13. The antiretroviral drugs which are used in combination should be used  in optimum 
schedules and appropriate dosage. 
 
14. The best effective treatment strategies involve simultaneous initiation of 
combination of anti HIV drugs with which the patient has not been priorly treated 
with and also which are not cross resistant with the drugs that the patient has already 
received.   
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INDICATIONS FOR STARTING ANTIRETROVIRAL THERAPY IN PATIENTS  
WITH HIV INFECTION: 
 
a) Acute infection syndrome 
 
b) Chronic infection 
 
1) Asymptomatic disease 
i. Pregnancy 
ii. CD4+T-cell count<350/µLa 
 
 2) Symptomatic disease (including HIV-associated nephropathy) 
 
c)  Post-exposure prophylaxis 
 
 
a
This is an area of controversy. Some will wait till CD4 comes to 200/µL, some others will treat  
 
everyone with a viral load >100,000 copies/ mL, whereas others will treat everyone regardless  
 
of CD4+ T-cell count. 
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INDICATIONS FOR CHANGE OF ANTIRETROVIRAL THERAPY IN PATIENTS 
WITH HIV INFECTION: 
 
i. Clinical deterioration 
 
ii. Persistently declining CD4+ T-cell numbers 
 
iii. Less than a 1-log drop in plasma HIV RNA by 4 weeks after the 
initiation of therapy 
 
iv. side effects 
 
v. A reproducible significant increase(defined as three- fold or greater) 
from the nadir of plasma HIV RNA level not attributable to 
intercurrent infection, vaccination, or test methodology. 
 
 
Generally when changing it should be initiation of at least two drugs to be effective in the given  
patient. The exception is the change made to manage toxicity, in case a single substitution is  
reasonable. 
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MATERIALS AND METHODS  
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MATERIALS AND METHODS 
 
The present study was undertaken with the following objectives. 
 
1. To define the prevalence of all surgical conditions among HIV infected patients  
 
attending the surgical /surgical super specialty OPDs/In Patients/surgical casualty of  
 
TMCH, Thanjavur. 
 
2. To study the prevalence of all surgical conditions among AIDS patients attending  
 
the ART OPD of TMCH, Thanjavur. 
 
3. To study about the various acute surgical emergencies in HIV /AIDS patients. 
 
4. To study the age and sex incidence in these patients. 
 
5. The outcome and type of the management. 
 
6. To study the presentation of these HIV patients with surgical disease. 
 
A study of prevalence of surgical conditions among HIV/AIDS patients in Thanjavur 
Medical College, Thanjavur 
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PATIENTS AND METHODS: 
      In this series I have taken sixty cases of HIV/AIDS patients for study during  
 JULY 2015 to AUGUST 2016. 
 
             These 60 cases were HIV/AIDS patients on or not on antiretroviral therapy and a few were  
 
newly diagnosed as HIV patients when they came for a surgical illness. Patients from the surgical  
 
OPD/In Patients/surgical specialty OPD/In Patients /ART OPDs were considered for this study.  
 
TYPE OF STUDY: 
Prospective and observational study. 
 
APPROVAL: 
Prior to starting the study approval has been obtained from the ethical  
committee of Thanjavur medical college, Thanjavur. 
 
 
STUDY PLACE: 
Thanjavur medical college and hospital,  
Thanjavur-613004. 
 
 
STUDY PERIOD: 
JULY 2015-AUGUST 2016. 
 
SAMPLE SIZE: 
Sixty (60). 
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INCLUSION CRITERIA: 
Allpatients presenting to the surgical /surgical specialties OPDs/In Patients/surgical  
Casualty /ART OPD with surgical illness were included.  
 
 
EXCLUSION CRITERIA: 
 The patients of medical/ medical speciality OPD were excluded. 
                 Patient with Medical conditions in ART OPD were excluded.  
Patients less than 12 years of age. 
Withdrawal /refusal of consent. 
 
 
PARAMETERS STUDIED: 
Data on patient’s name, age, sex, comorbid illness, number of years since  
ART, Presentation to the surgical OPD diagnosis, management and the outcome will be  
recorded statistical analysis will be carried out. 
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PROCEDURE: 
The questionnaire was designed depending on the objective of the study and  
it has been already piloted and suitably modified (proforma enclosed).  
It has the following details: 
 
1. Age and sex 
2. Occupation 
3. Socio economic status 
4. Complaints 
5. History of presenting illness 
6. Past history (comorbid illness) 
7. Clinical examination 
8. Investigations (Complete Blood Count, renal function test , BT , CT, urine 
routine and other investigations as required.) 
9. Radiological investigations as needed. 
10. Management (medical/surgical) 
11. Postoperative period  
12. Outcome 
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         After admission short history was taken and physical  
examinations was conducted on every patient admitted to general surgery/surgical 
superspecality department. Base line investigations, were routinely done followed by  
radiological investigations as required. Patients were explained about the nature of the  
disease process and the various possible line of management. All the essential  
information with regards to the study was explained either to the patient themselves or  
their guardian. Written informedconsent  was taken either from the patient or from their  
guardian willing to enroll themselves in the study. Detailed history was taken from the  
patients to establish the diagnosis properly. Thorough general and systemic examination  
was done in every case. Data collection sheet were filled in by myself. According to the  
patients diagnosis patients were treated either medically or surgically. Patients who  
required surgical management were taken up accordingly as elective or emergency 
for surgery. Strict aseptic universal precautions were followed during the surgery. After  
completion of the data it was compiled systematically. 
 
 
 
ETHICAL CONSIDERATIONS: 
All the patients/guardians were told about the study and also about the  
nature of illness and about the merits and demerits of the surgery if planned, expected  
results and outcomes. If the patient agrees, he/she can be selected for the study. The study  
didn’t have any significant risk/ it did not involve any special or additional investigation.  
It didn’t pose economic burden to any of the patient. The study was approved by the  
institutional review board before the commencement of data collection. Informed consent  
was taken from each patient/guardian. 
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DATA ANALYSIS: 
Data was analysed both manually and also by using computer. The data  
which was calculated were arranged in a systematic fashion, presented in various tables  
and figures and statistical analysis were done to evaluate the objectives of the present  
study with the help of statistical package for social science. 
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       PENILE ABSCESS IN AN AIDS PATIENT: 
 
Shown below is the picture of a patient who had urethral stricture with penile abscess for which 
Incision and Drainage of abscess with Supra Pubic Cystostomy was done. 
 
                             This case needs a special mention as  uncommon abscesses being common in 
AIDS patients. This patient is a 60 year old labourer on ART since 8 years. 
 
FIGURE 2:PENILE ABSCESS PATIENT ON SPC/INCISION AND DRAINAGE DONE:  
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HEMORRHOIDS IN AN AIDS PATIENT: 
This 36 years male waiter by occupation was 3 years on ART came with third degree hemorrhoids  
and secondary hemorrhoids with hypertrophied papillae 
 
 
 
FIGURE-3:MILLIGAN MORGAN OPEN HEMORRHOIDECTOMY 
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                        RESULTS 
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                               RESULTS: 
A prospective observational study was done to define the prevalence of  
all surgical conditions among HIV/AIDS patients. 60 patients were studied who satisfied  
the inclusion criteria. All these patients were taken from the surgical/surgical speciality 
departments of Thanjavur medical college, Thanjavur, from JULY 2015-AUGUST 2016. 
All patients were examined clinically and only important investigations were done before  
surgery. The results obtained are as follows: 
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AGE INCIDENCE: 
TABLE 1: Age distribution of patients. 
 
 
 
 
 
 
 
 
16.67% 
30% 
36.66% 
16.67% 
AGE INCIDENCE 
21-30 31-40
 AGE NO.OF. 
PATIENTS 
PERCENTILE 
21-30 10 16.67% 
31-40 18 30% 
41-50 22 36.66% 
51-60 10 16.67% 
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SEX INCIDENCE:  
TABLE 2: Sex distribution of the patients. 
  
 
 
 
 
 
 
MALES 
68% 
FEMALES 
32% 
 
0% 
SEX INCIDENCE 
MALES FEMALES
SEX NO.OF. 
PATIENTS 
PERCENTAGE 
MALE 41 68.33% 
FEMALE 19 31.67% 
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OCCUPATION INCIDENCE:  
TABLE 3: Occupation distribution of patients. 
 
 
 
 
 
 
 
 
 
 
 
 
16 
9 
5 
30 
0
5
10
15
20
25
30
35
LABOURER DRIVER SEX WORKER OTHERS
 
OCCUPATION 
 
NO.OF. 
PATIENTS 
PERCENTAGE 
 
        LABOURER 
 
16 
 
26.67% 
 
           DRIVER 
 
9 
 
15% 
 
      SEX WORKER 
 
5 
 
 
8.33% 
 
          OTHERS 
 
30 
 
50% 
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NO. OF YEARS ON ART: 
TABLE 4: ART distribution of patients. 
 
 
 
 
 
 
 
 
 
 
 
  
 
23 24 
13 
0
5
10
15
20
25
30
0 to 4 5 to 8 9 to 12
NO. OF YEARS ON ART 
NO. OF PATIENTS
 
NO. OF. YEARS 
SINCE ART 
 
NO.OF. 
PATIENTS 
 
PERCENTAGE 
 
0-4 
 
 
23 
 
38.33% 
 
5-8 
 
24 
 
40% 
 
9-12 
 
13 
 
21.67% 
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COMORBID ILLNESS INCIDENCE: 
TABLE 5: Diversity of comorbid illness among the patients. 
COMORBID ILLNESS NO.OF. PATIENTS PERCENTAGE 
DIABETES 
MELLITUS 
12 20% 
PULMONARY TB 8 13.33% 
HYPERTENSION 7 11.67% 
COPD 4 6.67% 
DIABETES & 
HYPERTENSION 
2 3.33% 
BRONCHIECTASIS 1 1.67% 
SEIZURE DISORDER                    1                1.67% 
NIL 25  41.66% 
 
 
 
DIABETUS MELLITUS  
20% 
DIABETUS MELLITUS 
/HYPERTENSION 
3% 
PULMONARY TB 
13% 
COPD 
7% SHTN 
12% 
BRONCHIECTASIS 
2% 
SEIZURE DISORDER 
2% 
NIL 
41% 
COMORBID ILLNESS 
DIABETUS MELLITUS DIABETUS MELLITUS /HYPERTENSION
PULMONARY TB COPD
SHTN BRONCHIECTASIS
SEIZURE DISORDER NIL
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CLINICAL PRESENTATION: 
The various clinical presentation among the patients are as follows: 
1. 6 cases of Inguinal Hernia 
 
2. GIT ELECTIVE 
 
a) 2 cases of  hemorrhoids 
 b) A case of duodenal ulcer 
c) A case of Abdomino pelvic cyst 
d) A case of right lobe liver abscess 
 
3. GIT EMERGENCY 
 
a) 3 cases of complicated appendicitis(abscess/perforation) 
b) 2 cases of duodenal ulcer perforation 
c) A case of obstructed incisional Hernia 
 
4.  Infectious(tuberculosis) 
a) obstructive hydrocephalus      
b) cold abscess neck 
c) psoas abscess 
d) empyema(2 cases) 
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5. Infectious (non-tuberculosis) 
a) Abscess 
 
i. Penile 
ii. Parotid 
iii. Perinephric 
iv. Ruptured spleenic 
v. Right Inguinal  
vi. Water can perineum/periurethral 
 
b) Non-abscess 
 
i. AGE  
ii. Cervicitis 
iii. Right Epididymoorchitis 
iv. Syphilitic penile ulcer 
v. Cellulitis left back 
vi. Necrotizing lymph adenitis neck node 
vii. Right  lower limb cellulitis 
viii. Urosepsis 
ix. Esophageal candidiasis 
x. Cystitis 
xi. Cervical lymph adenitis 
xii. Snake bite cellulitis 
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6. Malignancy  
a) Ca Stomach with liver metastasis 
b) Ca Cervix 
c) Ca Caecum 
d) Ca Stomach  
e) Ca Caecum with liver metastasis 
 
7. Trauma 
a) 3 cases of road traffic accidents( 1 with head injury) 
b) Accidental fall 
 
8. Others 
 
a)   Bilateral  varicose vein 
b) 2 cases of  Deep Venous Thrombosis 
c)  Right lower limb Filariasis 
d) 2 cases of sebaceous cyst 
e) 2 cases of  hydrocele 
f) Benign Prostatic Hyperplasia 
g) SOL Brain temporal lobe 
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CLINICAL PRESENTATION: 
TABLE 6: Diversity of clinical presentation among the patients 
 
CLINICAL 
PRESENTATION  
 
NO.OF. PATIENTS 
 
PERCENTAGE 
    INFECTIOUS(TB) 5 8.33% 
NON-TB         
INFECTIOUS 
18 30% 
     MALIGNANCY 5 8.33% 
            TRAUMA 4 6.67% 
 HERNIA 6 10% 
    GIT ELECTIVE 5 8.33% 
GIT EMERGENCY 6 10% 
          OTHERS 11 18.34% 
 
 
5 
18 
5 4 
6 5 6 
11 
0
2
4
6
8
10
12
14
16
18
20
CLINICAL PRESENTATION 
NO.OF.PATIENTS
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INFECTIOUS NON-TB: 
TABLE 7: Distribution of non- TB infectious disease                  
 
INFECTIOUS NON-TB 
 
NO.OF. PATIENTS 
 
PERCENTAGE 
 
ABSCESS 
 
6 
 
33.33% 
 
NON-ABSCESS 
 
12 
 
66.67% 
 
 
 
 
 
0 5 10 15 20 25 30 35
ABSCESS
NON-ABSCESS
NO.OF. PATIENTS 
NO.OF. PATIENTS
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TABLE 8: Distribution of diseases based on the organ system 
ORGAN SYSTEM NO.OF. PATIENTS PERCENTAGE 
GIT 17 28.34% 
UROGENITAL  
 
12 20% 
OTHERS 9 15% 
HERNIA 6 10% 
ACCIDENT 5 8.33% 
SOFT TISSUE 4 6.67% 
LYMPH NODES 3 5% 
CNS 2 3.33% 
RS/LUNGS 2 3.33% 
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TREATMENT GIVEN: 
TABLE 9: Diversity in the treatment given to the patients 
TREATMENT GIVEN TO 
THÉ PATIENTS 
NO.OF. PATIENTS PERCENTAGE 
MEDICALLY MANAGED 19 31.67% 
OPERATED/ELECTIVE 17 28.33% 
OPERATED/EMERGENCY 14 23.33% 
EXPIRED 3 5% 
CHEMOTHERAPY 2 3.33% 
ATT 2 3.33% 
ABSCONDED 1 1.67% 
RADIOLOGICAL 
INTERVENTION 
1 1.67% 
CONSERVATIVE 
MANAGEMENT 
1 1.67% 
 
 
19 
1 
14 
17 
2 
2 
1 1 
3 
TREATMENT GIVEN 
MEDICALLY MANAGED CONSERVATIVELY MANAGED OPERATED/EMERGENCY
OPERATED/ELECTIVE CHEMOTHERAPY ATT
ABSCONDED RADIOLOGICAL INTERVENTION EXPIRED
  
90 
 
  TABLE 10: Distribution of operated patients 
 
 
 
 
 
 
 
 
 
 
 
 
ELECTIVE, 17 
EMERGENCY, 14 
0
2
4
6
8
10
12
14
16
18
ELECTIVE EMERGENCY
OPERATED 
OPERATED
 
OPERATED 
CONDITIONS 
 
NO. OF. PATIENTS 
 
PERCENTAGE 
 
ELECTIVE 
 
17 
 
54.84% 
 
EMERGENCY 
 
14 
 
45.16% 
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DISCUSSION 
 This observational prospective study was conducted with 60  
patients with HIV/AIDS who presented with the surgical condition to the department of  
general surgery /surgical specialty/surgical casualty, Thanjavur medical college,  
Thanjavur. This study was carried out with the view to define the prevalence of surgical  
conditions among HIV/AIDS patients.  
 
                                             Age of the selected patients ranged 20-60 years with most of  
the patients between 41-50 years(22 patients = 36.66% of the patients).Among the total  
60 patients  68%(41 patients) were males and 32% (19 patients) were females. The ratio  
of male to  female is 2:1 and the predominant group is males. 
 
 The analysis of the comorbid illness, diabetes mellitus was the  predominant comorbid factor (12 
patients = 20% of patients) which is followed by pulmonary TB (8 patients = 13.33%) and next to  
TB is  hypertension (7 patients = 11.67%).  2 patients (3.33%) have both diabetes and 
hypertension. 25 patients/41.66% of  patients did not have any comorbid illness. 
 
 The occupation of the patients were variable. Among the group  patients were mainly  
labourers and drivers. About 27%(16 patients) of the patients were laborers and about  
15% of the  patients (9 patients) were drivers. 8.33% of them (5 patients) were sex  
Workers. 
                                           The number of years on ART of the patients were in the  
range between 0-12 years. Among the patients most of them were in the antiretroviral  
therapy(ART) between  5-8 years and it is about 40% of the total patients (24 patients).  
Next to this range, patients were on ART between  0-4 years (23 patients = 38.33%). 
Hence patients on ART between 0-4 years and 4-8 years are more or less the same, 
38.33% and 40% respectively 
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                                             In the statistical analysis of the clinical presentation of the  
patients it is found that the patients were mostly having non Tuberculous infectious   
disease. It is about 30%(18 patients) of the total patients. Next to that, the  GIT 
emergencies and hernia (6 patients = 10% of the patients) have equal importance  
followed by the malignancy, GIT electives and the TB related infections (5 patients =  
8.33% of the patients each). 
 
 
                                                Among the 18 patients with non TB infections 12 patients  
had non-abscess related conditions and 6 had abscess. Those abscesses were uncommon  
abscesses. Hence uncommon abscesses were common in HIV/AIDS patients.  
 
 
                                               On analyzing the study of the 60 HIV/AIDS patients 17  
patients had gastro intestinal tract problems (28.34% of the patients ) ,12 patients had   
urogenital problems (20% of the patients) and 6 patients had hernia (10% of patients).                                         
 
 
                                           In the study of 60 HIV/AIDS patients about 31 patients were  
Operated and it is about 51.67% of the total patients followed by which 19 patients were  
medically managed (31.67% of the patients) 
 
                                      Among the 31 operated HIV/AIDS patients 17 patients (55% of  
the operated patients) were operated in elective  and 14 patients (45% of the operated  
patients) were operated in emergency. 
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LIMITATIONS OF THE STUDY  
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 LIMITATIONS OF THE STUDY  
 
As this study has been carried out over a limited period of time with a limited number of  
patients, it could not have been large enough to be of  reasonable precision. 
All the facts and figures mentioned here vary considerably from those of large series  
covering wide range of time, but still then ,as the cases of this studywere collected from  
a tertiary care level hospital in our country, this study has some credentialsin defining  
the prevalence of surgical conditions among HIV/AIDS patients. 
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CONCLUSION 
 
This prospective observational study was conducted in the department of 
general surgery, Thanjavur medical college,Thanjavur. It can be concluded from the findings of  
the study that 
 
 
1. Males most commonly present with surgical conditions. 
 
2.  The common age group is between 41-50 years 
. 
3. Majority of  the patients are laborers. 
 
4.  Most of the patients who present to the surgical Outpatient/Inpatient department are on 
ART since 0-4 years or 5-8 years. 
 
5. The common comorbid illness among HIV/AIDS patients is diabetes mellitus followed by 
pulmonary tuberculosis. 
 
6. The commonest organ system involved among the surgical patients is gastro intestinal 
system. 
 
7. They present to the surgical Outpatient/Inpatient department with non- tuberculous 
infectious disease which are mostly non-abscess. 
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8. About 52% of patients who present to the surgical Outpatient/Inpatient department/casualty 
are operated among whom 28.33% are operated electively.  
 
9. Among elective surgeries surgery for hernia is commonest.  
 
10. Among the emergencies complicated appendicitis/ abscess is common. 
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RECOMMENDATIONS 
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RECOMMENDATIONS 
On the basis of the findings of the study, the following recommendations can be made: 
1. Many HIV/AIDS patients present to the surgical OPD/casualty with surgical illness 
unrelated to HIV/AIDS(hernia, hemmorhoids, sebaceous cyst, hydrocele, 
malignancies) and also with surgical illness in a virulent form due to HIV/AIDS 
(Appendicular abscess, ruptured splenic abscess, water can perineum). 
 
2. Abscesses at uncommon sites  consider HIV serology (parotid, penile, inguinal 
abscesses). 
 
3. As a routine do HIV serology for all surgical cases  
 
4. HIV patients life expectancy is extended by ART hence they present with surgical 
conditions unrelated to HIV/AIDS, all surgeons must be prepared to operate on them. 
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DATA COLLECTION CHART 
QUESTIONAIRE 
PATIENT DETAILS : 
 
Name :                         Age:                   Sex: 
  
IP No. 
 
Occupation : 
 
ON ADMISSION : 
 
Complaints : 
 
History of presenting illness : 
 
PAST HISTORY : 
Number of years since diagnosed as HIV / AIDS : 
Number of years on ART : 
 Co-Morbid illness : 
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CLINICAL EXAMINATION : 
Pulse :                  BP :                     RR:                 Temp: 
 
Pallor:                   Icterus: 
 
CVS:                     RS: 
 
P/A: 
 
INVESTGATIONS : 
Hemogram: Renal Function Test : 
 
Liver Function Test :                                Random Blood Sugar:  
 
BT/CT:                 Blood Grouping:        
 
ECG:                                    CXR: 
 
Management: 
 
Operative Procedure (if any) : 
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                   MASTER CHART 
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S.NO NAME IP/OP NO AGE SEX OCCUPATION COMORBID ILLNESS
NO.OF.YEARS 
SINCE ART CLINICAL PRESENTATION TREATMENT GIVEN
1 R.Vasudevan 45367 30 M Assistant director NIL 5 B/L varicose veins Operated/Elective/Trendlenberg
2 M.Faathima 46758 45 F Tailor NIL 10 Abdominal pain / AGE  Expired /Pneumocystis pneumonia
3 S.Alagan 32453 45 M Farmer DM newly diagnosed Hemmorhoids Conservative treatment
4 K.Alagappan 985 40 M Not specific NIL 5 Left Inguinal Hernia Operated/Elective/Hernioplasty
5 A.Murugan 34258 50 M Labourer NIL 1 Water can perineum Medically managed
6 R.Vasantha 12310 55 F Home maker DM 7 Ca Stomach with liver secondaries Absconded
7 S.Manian 13567 30 M Labourer NIL 3 Obstructive Hydrocephalus Operated/Emergency/VP Shunt
8 M.Senthil kumar 3278 45 M Fisher man DM 5 50% Thermal Burns Expired
9 J.Poongumaran 6578 36 M PWD worker NIL 7 RTA with Head injury Expired
10 S.Priya 5467 30 F Sex worker NIL 3 Cervicitis Medically managed
11 M.Valavambal 9870 60 F Homemaker DM 12 Ca cervix stage 3B Chemotherapy
12 P.Panneer selvam 12367 60 M labourer NIL 8 Penile abscess/stricture  Operated/Emergency/SPC
13 G.Gnanasekar 24378 45 M Farmer TB 7 Rt Epididymo orchitis Medically managed
14 K.Kanchana 6238 55 F Sex worker NIL 9 right Parotid abscess Operated/Emergency/I&D
15 T.Paarthiban 2865 46 M Labourer DM 5 Penile ulcer / syphilis Medically managed
16 S.Muthukumar 2132 38 M shop keeper NIL 11 Appendicular perforation Operated/Emergency/Appendectomy
17 A.Ranjitham 3456 32 F Labourer DM/HT 8 Obstructed Incisional Hernia Operated/Elective/repair
18 M.Periasamy 9765 37 M Driver NIL 8 Appendicular Abscess Operated/Emergency/Appendectomy
19 U.Mariamma 4356 44 F Labourer Seizure disorder 3 Cellulitis left back Medically managed
20 P.Govindhan 5774 39 M Mason NIL 4 Rt inguinal hernia Operated/Elective/Hernioplasty
21 U.Prasanth 14237 23 M Driver COPD 7 Rt Hydrocele Operated/Elective/Eversion of sac
22 K.Balakrishna 25258 45 M Labourer NIL 9 Necrotising lymphadenitis-neck node medically managed
23 G.John 32327 54 M  Baker HT/CKD/Anemia 3 Sebaceous cyst back Operated/Elective/Excision
24 A.Nazeer 5322 34 M Farmer NIL 12 Left Inguinal Hernia Operated/Elective/Hernioplasty
25 R.Munniappan 2345 50 M Engineer HT/CAD newly diagnosed Ca Caecum Operated/Elective/Rt.Hemicolectomy
26 W.Rathna 7654 35 F Labourer HT 6 Lt lower limb DVT Medically managed
27 T.Venkatesh 34679 27 M Carpenter NIL 2 Rt indirect inguinal hernia Operated/Elective/Hernioplasty
28 S.Keerthika 12546 45 F Home maker DM 1 Ca stomach Operated/Elective/Gastrectomy
29 R.Sangeetha 6789 45 F Sex worker TB 5 Rt Lower limb cellulitis Medically managed
30 S.Santhanaam 34526 47 M Labourer HT 7 Urosepsis/Rt Pyelonephritis Medically managed
31 K.Kamalnathan 125 32 M Driver TB 4 Duodenal Ulcer Medically managed
32 T.Khalid 2124 43 M Security DM 5 Dysphagia/oesophageal candidiasis Medically managed
33 U.Nishanth 4558 54 M Driver COPD  6 lt Perinephric Abscess Operated/emergency/drained
34 K.Paarvathi 45745 26 F Home maker NIL 1 Cystitis Medically managed
35 G.Kannan 21457 48 M Painter NIL 8 Accidental fall/contusion Rt thigh Medically managed
36 R.Yanesswaran 4512 59 M Labourer HT/CAD 9 Lt inguinal hernia Operated/Elective/Hernioplasty
37 J.Praveen 1542 57 M Driver TB 11 RTA with Multiple injuries Suturing under LA/Emergency
38 T.Naveen 7568 48 M Labourer NIL 7 Rt Lower limb filariasis Medically managed
39 G.Mahesh 49586 36 M Waiter DM 3 Hemmorhoids Operated/elective/hemmorhoidectomy
40 N.Sakthivel 45127 34 M Driver NIL 1 DVT Both the legs Medically managed/anticoagulants
41 K.Radhika 8505 28 F Lab technician HT 2 Right Cervical Lymphadenitis Medically managed/antibiotics
42 J.Arulanantham 4501 39 M Labourer NIL 4  Ruptured Spleenic Abscess Operated/Emergency/Spleenectomy
43 T.Elango 7495 56 M Driver Bronchiectasis 8 Appendicular perforation Operated/Emergency/Appendectomy
44 R.Rajeshwari 44475 44 F PWD worker DM 9 Abdomino Pelvic Cyst/Lt Adenexal Operated/Elective/cystectomy
45 A.Shiva 14254 37 M Carpenter NIL 4 Rt lobe liver Abscess Aspiration (USG Guided)
46 K.Mugilan 15426 48 M Driver COPD 11 Lt inguinal hernia Operated/Elective/Hernioplasty
47 T.Jolitha 4524 26 F Accountant NIL 1 Cold abscess Rt side neck ATT 
48 S.Sherin 4587 45 F Labourer TB 8 Lt Psoas Abscess ATT 
49 A.Kupan 9856 35 M Construction worker DM/HT 8 Perforation Peritonitis Operated/Emergency/omental patch closure
50 A.Kamal 4857 33 M Labourer NIL 4 Snake Bite Lt Lower limb Cellulitis Medically managed
51 L.Lingesan 7845 31 M Milk Man TB 4 RTA with Abrasion right hand Medically managed
52 M.Lalitha 6985 42 F Home maker NIL 5 Empyema Rt Lung Rt ICD/Emergency
53 T.Surya 2541 50 M Cook DM 7 Lt Hydrocele Operated/Elective/Eversion of sac
54 C.Chinnasaami 14526 23 M Labourer DM 2 SOL-Brain Lt Temporal Lobe Operated/Elective/Excision
55 U.Usha 48769 40 F Lab technician COPD 6 Sebaceous cyst Operated/Elective/Excision
56 K.Kumaravelu 4524 30 M Driver NIL 3 TB Empyema Rt Lung Rt ICD/Emergency
57 T.Gowsalya 85 48 F Sex worker NIL 4 Ca Caecum with Liver metastasis Chemotherapy
58 F.Syed 452 60 M Labourer TB 11 BPH Medically managed
59 E.Rubika 1542 35 F Sex worker NIL 12  Rt Inguinal Abscess Drained/I & D/Emergency
60 S.Paneer 8456 45 M shop keeper DM 9 Perforation Peritonitis Operated/Emergency/omental patch closure  
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